Drug Delivery Technology to the CNS in the Treatment of Brain Tumors: The Sherbrooke Experience
Drug delivery to the central nervous system (CNS) remains a challenge in neuro-oncology. Despite decades of research in this field, no consensus has emerged as to the best approach to tackle this physiological limitation. Moreover, the relevance of doing so is still sometimes questioned in the commu...
Main Author: | David Fortin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/11/5/248 |
Similar Items
-
Management of Primary Central Nervous System Lymphoma Using Intra-Arterial Chemotherapy With Osmotic Blood-Brain Barrier Disruption: Retrospective Analysis of the Sherbrooke Cohort
by: Christian Iorio-Morin, et al.
Published: (2021-01-01) -
Beyond the Blood:Brain Barrier: The Importance of Central Nervous System (CNS) Pharmacokinetics for the Treatment of CNS Tumors, Including Diffuse Intrinsic Pontine Glioma
by: Katherine Elizabeth Warren
Published: (2018-07-01) -
CNS Tumors and Neurofibromatosis
by: J Gordon Millichap
Published: (1989-02-01) -
Strategies for Improved Intra-arterial Treatments Targeting Brain Tumors: a Systematic Review
by: Rui Huang, et al.
Published: (2020-08-01) -
Obstacles to Brain Tumor Therapy: Key ABC Transporters
by: Juwina Wijaya, et al.
Published: (2017-11-01)